Northern California is home to some of the top MS research institutions in the world. The National MS Society has funded nearly $13 million in active research grants to researchers at UC San Francisco, Stanford, UC Davis and the Gladstone Institute and several other organizations are undertaking clinical trials. Here are some local ones you can participate in.
UC Davis - Fingolimod Trial
The UC Davis Multiple Sclerosis Program is pleased to announce its participation in a study of a new investigational
treatment, fingolimod, for primary progressive multiple sclerosis. The goal is to determine whether this new investigational treatment will slow the progression of disability and evidence the changes in the MRI.
Some criteria for participation are:
- Age 25 through 65 years of age
- Have a diagnosis of primary progressive multiple sclerosis with at least one year of progression of symptoms
- Time since first reported symptoms between 2 and 10 years with some disability currently
- Have no significant cardiac or respiratory conditions
For information concerning the study, please contact the UC Davis Multiple Sclerosis Program at (916) 734-6276.
UCSF - MS Center
There are several clinical studies open for enrollment, including:
- Natalizumab Effects
- Predicting Factors Study
- Riluzole Study
- Stress Study
- CIS Study
- Genetic Study